Gender differences in drug toxicity
Clinical data suggest that gender dimorphic profiles are emerging in terms of both drug efficacy and adverse drug reactions (ADRs). With an increasing emphasis on individualised therapies and the need to prevent drug attrition there is a compelling need to understand the molecular basis for gender d...
Gespeichert in:
Veröffentlicht in: | Trends in pharmacological sciences (Regular ed.) 2010-03, Vol.31 (3), p.108-114 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 114 |
---|---|
container_issue | 3 |
container_start_page | 108 |
container_title | Trends in pharmacological sciences (Regular ed.) |
container_volume | 31 |
creator | Nicolson, Tamara J Mellor, Howard R Roberts, Ruth R.A |
description | Clinical data suggest that gender dimorphic profiles are emerging in terms of both drug efficacy and adverse drug reactions (ADRs). With an increasing emphasis on individualised therapies and the need to prevent drug attrition there is a compelling need to understand the molecular basis for gender dimorphic profiles in ADRs and the consequences. Classes of agents exhibiting gender-based variation in pharmaceutical efficacy and toxicity include anaesthetics, HIV-1 therapies and antiarrhythmic drugs. Body weight differences are often cited as a reason for differences in drug pharmacokinetics and subsequent toxicity. However, some studies accounted for these factors and still found significance suggesting that dosage versus body weight does not explain the outcome. Here, we present an overview of current understanding of gender-specific drug toxicity and present rational molecular explanations for these adverse events. There is mounting evidence in support of hormonal effects underpinning the majority of the ADR differences observed between the sexes. |
doi_str_mv | 10.1016/j.tips.2009.12.001 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_746154802</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0165614709002077</els_id><sourcerecordid>733123941</sourcerecordid><originalsourceid>FETCH-LOGICAL-c467t-bfdd7684871855ff10690d59a989d9e09dfc1b5eceaf3c526fde6f3bfbe366243</originalsourceid><addsrcrecordid>eNqFkUFr3DAQRkVpabZp_0AOYaGHnuzOSLZkQQiU0KaFQA5Jz8KWRkUbr72R7NL995HZJIcc0tNc3vcObxg7QSgRUH7dlFPYpZID6BJ5CYBv2AobJQqhRP2WrTJUFxIrdcQ-pLQBACE4vmdHHBBVUzUr9vmSBkdx7YL3FGmwlNZhWLs4_1lP479gw7T_yN75tk_06fEes98_vt9e_Cyuri9_XXy7Kmwl1VR03jkls1VhU9feI0gNrtatbrTTBNp5i11NllovbM2ldyS96HxHQkpeiWP25eDdxfF-pjSZbUiW-r4daJyTUZXEumqA_58UArnQFWaSH0gbx5QiebOLYdvGvUEwS0WzMUtFs1Q0yE2umEenj_q525J7njxly8DZAaCc42-gaJINSzwXItnJuDG87j9_Mbd9GIJt-zvaU9qMcxxyaIMm5YG5Wf64vBE0AAelxAOLIZbs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733123941</pqid></control><display><type>article</type><title>Gender differences in drug toxicity</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Nicolson, Tamara J ; Mellor, Howard R ; Roberts, Ruth R.A</creator><creatorcontrib>Nicolson, Tamara J ; Mellor, Howard R ; Roberts, Ruth R.A</creatorcontrib><description>Clinical data suggest that gender dimorphic profiles are emerging in terms of both drug efficacy and adverse drug reactions (ADRs). With an increasing emphasis on individualised therapies and the need to prevent drug attrition there is a compelling need to understand the molecular basis for gender dimorphic profiles in ADRs and the consequences. Classes of agents exhibiting gender-based variation in pharmaceutical efficacy and toxicity include anaesthetics, HIV-1 therapies and antiarrhythmic drugs. Body weight differences are often cited as a reason for differences in drug pharmacokinetics and subsequent toxicity. However, some studies accounted for these factors and still found significance suggesting that dosage versus body weight does not explain the outcome. Here, we present an overview of current understanding of gender-specific drug toxicity and present rational molecular explanations for these adverse events. There is mounting evidence in support of hormonal effects underpinning the majority of the ADR differences observed between the sexes.</description><identifier>ISSN: 0165-6147</identifier><identifier>EISSN: 1873-3735</identifier><identifier>DOI: 10.1016/j.tips.2009.12.001</identifier><identifier>PMID: 20117848</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Advanced Basic Science ; Carrier Proteins - metabolism ; Drug-Related Side Effects and Adverse Reactions - etiology ; Female ; Hormones - metabolism ; Human immunodeficiency virus 1 ; Humans ; Male ; Pharmaceutical Preparations - metabolism ; Sex Characteristics</subject><ispartof>Trends in pharmacological sciences (Regular ed.), 2010-03, Vol.31 (3), p.108-114</ispartof><rights>Elsevier Ltd</rights><rights>2009 Elsevier Ltd</rights><rights>2009 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c467t-bfdd7684871855ff10690d59a989d9e09dfc1b5eceaf3c526fde6f3bfbe366243</citedby><cites>FETCH-LOGICAL-c467t-bfdd7684871855ff10690d59a989d9e09dfc1b5eceaf3c526fde6f3bfbe366243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.tips.2009.12.001$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20117848$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nicolson, Tamara J</creatorcontrib><creatorcontrib>Mellor, Howard R</creatorcontrib><creatorcontrib>Roberts, Ruth R.A</creatorcontrib><title>Gender differences in drug toxicity</title><title>Trends in pharmacological sciences (Regular ed.)</title><addtitle>Trends Pharmacol Sci</addtitle><description>Clinical data suggest that gender dimorphic profiles are emerging in terms of both drug efficacy and adverse drug reactions (ADRs). With an increasing emphasis on individualised therapies and the need to prevent drug attrition there is a compelling need to understand the molecular basis for gender dimorphic profiles in ADRs and the consequences. Classes of agents exhibiting gender-based variation in pharmaceutical efficacy and toxicity include anaesthetics, HIV-1 therapies and antiarrhythmic drugs. Body weight differences are often cited as a reason for differences in drug pharmacokinetics and subsequent toxicity. However, some studies accounted for these factors and still found significance suggesting that dosage versus body weight does not explain the outcome. Here, we present an overview of current understanding of gender-specific drug toxicity and present rational molecular explanations for these adverse events. There is mounting evidence in support of hormonal effects underpinning the majority of the ADR differences observed between the sexes.</description><subject>Advanced Basic Science</subject><subject>Carrier Proteins - metabolism</subject><subject>Drug-Related Side Effects and Adverse Reactions - etiology</subject><subject>Female</subject><subject>Hormones - metabolism</subject><subject>Human immunodeficiency virus 1</subject><subject>Humans</subject><subject>Male</subject><subject>Pharmaceutical Preparations - metabolism</subject><subject>Sex Characteristics</subject><issn>0165-6147</issn><issn>1873-3735</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUFr3DAQRkVpabZp_0AOYaGHnuzOSLZkQQiU0KaFQA5Jz8KWRkUbr72R7NL995HZJIcc0tNc3vcObxg7QSgRUH7dlFPYpZID6BJ5CYBv2AobJQqhRP2WrTJUFxIrdcQ-pLQBACE4vmdHHBBVUzUr9vmSBkdx7YL3FGmwlNZhWLs4_1lP479gw7T_yN75tk_06fEes98_vt9e_Cyuri9_XXy7Kmwl1VR03jkls1VhU9feI0gNrtatbrTTBNp5i11NllovbM2ldyS96HxHQkpeiWP25eDdxfF-pjSZbUiW-r4daJyTUZXEumqA_58UArnQFWaSH0gbx5QiebOLYdvGvUEwS0WzMUtFs1Q0yE2umEenj_q525J7njxly8DZAaCc42-gaJINSzwXItnJuDG87j9_Mbd9GIJt-zvaU9qMcxxyaIMm5YG5Wf64vBE0AAelxAOLIZbs</recordid><startdate>20100301</startdate><enddate>20100301</enddate><creator>Nicolson, Tamara J</creator><creator>Mellor, Howard R</creator><creator>Roberts, Ruth R.A</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20100301</creationdate><title>Gender differences in drug toxicity</title><author>Nicolson, Tamara J ; Mellor, Howard R ; Roberts, Ruth R.A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c467t-bfdd7684871855ff10690d59a989d9e09dfc1b5eceaf3c526fde6f3bfbe366243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Advanced Basic Science</topic><topic>Carrier Proteins - metabolism</topic><topic>Drug-Related Side Effects and Adverse Reactions - etiology</topic><topic>Female</topic><topic>Hormones - metabolism</topic><topic>Human immunodeficiency virus 1</topic><topic>Humans</topic><topic>Male</topic><topic>Pharmaceutical Preparations - metabolism</topic><topic>Sex Characteristics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nicolson, Tamara J</creatorcontrib><creatorcontrib>Mellor, Howard R</creatorcontrib><creatorcontrib>Roberts, Ruth R.A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Trends in pharmacological sciences (Regular ed.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nicolson, Tamara J</au><au>Mellor, Howard R</au><au>Roberts, Ruth R.A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gender differences in drug toxicity</atitle><jtitle>Trends in pharmacological sciences (Regular ed.)</jtitle><addtitle>Trends Pharmacol Sci</addtitle><date>2010-03-01</date><risdate>2010</risdate><volume>31</volume><issue>3</issue><spage>108</spage><epage>114</epage><pages>108-114</pages><issn>0165-6147</issn><eissn>1873-3735</eissn><abstract>Clinical data suggest that gender dimorphic profiles are emerging in terms of both drug efficacy and adverse drug reactions (ADRs). With an increasing emphasis on individualised therapies and the need to prevent drug attrition there is a compelling need to understand the molecular basis for gender dimorphic profiles in ADRs and the consequences. Classes of agents exhibiting gender-based variation in pharmaceutical efficacy and toxicity include anaesthetics, HIV-1 therapies and antiarrhythmic drugs. Body weight differences are often cited as a reason for differences in drug pharmacokinetics and subsequent toxicity. However, some studies accounted for these factors and still found significance suggesting that dosage versus body weight does not explain the outcome. Here, we present an overview of current understanding of gender-specific drug toxicity and present rational molecular explanations for these adverse events. There is mounting evidence in support of hormonal effects underpinning the majority of the ADR differences observed between the sexes.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>20117848</pmid><doi>10.1016/j.tips.2009.12.001</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0165-6147 |
ispartof | Trends in pharmacological sciences (Regular ed.), 2010-03, Vol.31 (3), p.108-114 |
issn | 0165-6147 1873-3735 |
language | eng |
recordid | cdi_proquest_miscellaneous_746154802 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Advanced Basic Science Carrier Proteins - metabolism Drug-Related Side Effects and Adverse Reactions - etiology Female Hormones - metabolism Human immunodeficiency virus 1 Humans Male Pharmaceutical Preparations - metabolism Sex Characteristics |
title | Gender differences in drug toxicity |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T08%3A15%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gender%20differences%20in%20drug%20toxicity&rft.jtitle=Trends%20in%20pharmacological%20sciences%20(Regular%20ed.)&rft.au=Nicolson,%20Tamara%20J&rft.date=2010-03-01&rft.volume=31&rft.issue=3&rft.spage=108&rft.epage=114&rft.pages=108-114&rft.issn=0165-6147&rft.eissn=1873-3735&rft_id=info:doi/10.1016/j.tips.2009.12.001&rft_dat=%3Cproquest_cross%3E733123941%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733123941&rft_id=info:pmid/20117848&rft_els_id=S0165614709002077&rfr_iscdi=true |